Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings

Shares (Q2 2026)
774,055
Value
$13.4M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of AMRX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026774,055$13.4M<0.1%−945,899−55.0%ReducedHolders
Q1 20261,719,954$21.4M<0.1%−941,900−35.4%ReducedHolders
Q4 20252,661,854$33.5M<0.1%+1,096,643+70.1%AddedHolders
Q3 20251,565,211$15.7M<0.1%+641,567+69.5%AddedHolders
Q2 2025923,644$7.47M<0.1%+907,808+5,732.6%AddedHolders
Q1 202515,836$132.7K<0.1%+15,836NewHolders
Q3 20240$00.0%−89,895−100.0%Sold outHolders
Q2 202489,895$570.8K<0.1%−136,309−60.3%ReducedHolders
Q1 2024226,204$1.37M<0.1%−439,832−66.0%ReducedHolders
Q4 2023666,036$4.04M<0.1%−208,880−23.9%ReducedHolders
Q3 2023874,916$3.69M<0.1%+252,690+40.6%AddedHolders
Q2 2023622,226$1.93M<0.1%−7,883−1.3%ReducedHolders
Q1 2023630,109$875.9K<0.1%−58,728−8.5%ReducedHolders
Q4 2022688,837$1.37M<0.1%+427,987+164.1%AddedHolders
Q3 2022260,850$527.0K<0.1%+71,923+38.1%AddedHolders
Q2 2022188,927$601.0K<0.1%−65,072−25.6%ReducedHolders
Q1 2022253,999$1.06M<0.1%+95,977+60.7%AddedHolders
Q4 2021158,022$757.0K<0.1%+139,980+775.9%AddedHolders
Q3 202118,042$96.0K<0.1%+18,042NewHolders
Q2 20210$00.0%−122,774−100.0%Sold outHolders
Q1 2021122,774$826.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.